Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.3.9213.9000
Address
1 Corporate Avenue Rowville, Victoria (VIC) 3178
Description
Universal Biosensors, Inc. engages in the research, development and manufacture of medical diagnostics test systems for point-of-care professional and home use. Its products include blood glucose monitoring, coagulation testing, immunoassay, and molecular diagnostics. The company was founded in 2001 and is headquartered in Rowville, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.06 - 0.17
Trade Value (12mth)
US$3,247.00
1 week
1.64%
1 month
-15.07%
YTD
-37.37%
1 year
-63.53%
All time high
2.08
EPS 3 yr Growth
-17.00%
EBITDA Margin
-257.20%
Operating Cashflow
-$8m
Free Cash Flow Return
-57.90%
ROIC
-67.00%
Interest Coverage
-157.20
Quick Ratio
2.80
Shares on Issue (Fully Dilluted)
298m
HALO Sector
Healthcare
Next Company Report Date
04-Mar-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
15 April 25 |
2025 Notice of Meeting / Proxy Statement
×
2025 Notice of Meeting / Proxy Statement |
04 April 25 |
Preliminary Proxy Statement/Notice of Meeting
×
Preliminary Proxy Statement/Notice of Meeting |
02 April 25 |
Appendix 3Z - John Sharman
×
Appendix 3Z - John Sharman |
01 April 25 |
Managing Director & Chief Executive Officer Appointment
×
Managing Director & Chief Executive Officer Appointment |
25 March 25 |
Notification of cessation of securities - UBI
×
Notification of cessation of securities - UBI |
17 March 25 |
Chairman's Letter
×
Chairman's Letter |
26 February 25 |
Appendix 4E and Annual Report FY2024
×
Appendix 4E and Annual Report FY2024 |
26 February 25 |
FY2024 Appendix 4G and Corporate Governance Statement
×
FY2024 Appendix 4G and Corporate Governance Statement |
26 February 25 |
FY2024 Annual Results Presentation
×
FY2024 Annual Results Presentation |
12 February 25 |
Change of Company Secretary
×
Change of Company Secretary |
29 January 25 |
Investor Presentation - The Microcap Conference USA
×
Investor Presentation - The Microcap Conference USA |
24 January 25 |
December 2024 Quarterly Activity Report and Appendix 4C
×
December 2024 Quarterly Activity Report and Appendix 4C |
23 January 25 |
Petrackr deals with Chewy and Amazon
×
Petrackr deals with Chewy and Amazon |
17 January 25 |
Initial Director's Interest Notice - John Sharman
×
Initial Director's Interest Notice - John Sharman |
17 January 25 |
Initial Director's Interest Notice - Peter Mullin
×
Initial Director's Interest Notice - Peter Mullin |
15 January 25 |
UBI Board Additions
×
UBI Board Additions |
10 January 25 |
Notification of cessation of securities - UBI
×
Notification of cessation of securities - UBI |
31 December 24 |
Appointment of Peter Mullin as Finance Director & CFO
×
Appointment of Peter Mullin as Finance Director & CFO |
19 November 24 |
UBI signs NDC as its distribution partner for Xprecia Prime
×
UBI signs NDC as its distribution partner for Xprecia Prime |
08 November 24 |
UBI signs Henry Schein as distribution partner for Xprecia
×
UBI signs Henry Schein as distribution partner for Xprecia |
31 October 24 |
September 2024 Quarterly Activity Report and Appendix 4C
×
September 2024 Quarterly Activity Report and Appendix 4C |
31 October 24 |
Q3 2024 Results
×
Q3 2024 Results |
31 October 24 |
Q3 2024 Results Presentation
×
Q3 2024 Results Presentation |
08 October 24 |
Notification regarding unquoted securities - UBI
×
Notification regarding unquoted securities - UBI |
26 August 24 |
Xprecia Prime deal in India (Revised)
×
Xprecia Prime deal in India (Revised) |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.